{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:01:22Z","timestamp":1792202482338,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.molcel.2022.01.029","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T10:36:19Z","timestamp":1645698979000},"page":"1249-1260.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma"],"prefix":"10.1016","volume":"82","author":[{"given":"Xin","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-2893","authenticated-orcid":false,"given":"Ningwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1533-8568","authenticated-orcid":false,"given":"Xu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2022.01.029_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib2","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/febs.14782","article-title":"Structural, biochemical and biophysical characterization of recombinant human fumarate hydratase","volume":"286","author":"Ajalla Aleixo","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.molcel.2022.01.029_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2006.03.005","article-title":"S-(2-succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate","volume":"450","author":"Alderson","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molcel.2022.01.029_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.1236188","article-title":"Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress","volume":"341","author":"Bassi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molcel.2022.01.029_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/db07-0838","article-title":"Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress","volume":"57","author":"Blatnik","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.molcel.2022.01.029_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41585-019-0233-z","article-title":"Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities","volume":"16","author":"Brodziak","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.molcel.2022.01.029_bib7","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.molcel.2022.01.029_bib8","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.1211962109","article-title":"Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240","volume":"109","author":"Fenton","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2022.01.029_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1737","article-title":"Mitochondrial tumour suppressors: a genetic and biochemical update","volume":"5","author":"Gottlieb","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2022.01.029_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tibs.2014.02.006","article-title":"PTEN function: the long and the short of it","volume":"39","author":"Hopkins","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molcel.2022.01.029_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2022.01.029_bib12","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.abb9818","article-title":"Succination inactivates gasdermin D and blocks pyroptosis","volume":"369","author":"Humphries","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molcel.2022.01.029_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.aan4665","article-title":"Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity","volume":"360","author":"Kornberg","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.molcel.2022.01.029_bib15","doi-asserted-by":"crossref","first-page":"100546","DOI":"10.1016\/j.gore.2020.100546","article-title":"Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)","volume":"32","author":"Lee","year":"2020","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.molcel.2022.01.029_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81663-3","article-title":"Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib17","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1021\/jo00274a042","article-title":"A highly efficient and large-scale synthesis of (2s,3s)-[2,3-2h2]aspartic and (2s,3r)-[3\u20132h]aspartic acids via an immobilized aspartase-containing microbial cell system","volume":"54","author":"Lee","year":"1989","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.molcel.2022.01.029_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","article-title":"The functions and regulation of the PTEN tumour suppressor: new modes and prospects","volume":"19","author":"Lee","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molcel.2022.01.029_bib19","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"Li","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molcel.2022.01.029_bib20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1158\/2159-8290.CD-18-1354","article-title":"The metabolic basis of kidney cancer","volume":"9","author":"Linehan","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.molcel.2022.01.029_bib21","doi-asserted-by":"crossref","first-page":"14249","DOI":"10.1038\/s41598-017-14759-1","article-title":"Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI","volume":"7","author":"Linxweiler","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molcel.2022.01.029_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccell.2019.01.020","article-title":"Inhibition of nuclear PTEN tyrosine phosphorylation enhances glioma radiation sensitivity through attenuated DNA repair","volume":"35","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.32783","article-title":"Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer","volume":"147","author":"Myers","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molcel.2022.01.029_bib24","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.95.23.13513","article-title":"The lipid phosphatase activity of PTEN is critical for its tumor supressor function","volume":"95","author":"Myers","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2022.01.029_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccr.2011.08.024","article-title":"An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma","volume":"20","author":"Ooi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2014.03.027","article-title":"Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function","volume":"157","author":"Papa","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib27","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molcel.2022.01.029_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molcel.2017.01.027","article-title":"Phosphoglycerate kinase 1 phosphorylates Beclin1 to induce autophagy","volume":"65","author":"Qian","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.molcel.2019.08.006","article-title":"PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1","volume":"76","author":"Qian","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2159-8290.CD-17-0712","article-title":"Conversion of PRPS hexamer to monomer by AMPK-mediated phosphorylation inhibits nucleotide synthesis in response to energy stress","volume":"8","author":"Qian","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.molcel.2022.01.029_bib31","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molcel.2022.01.029_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semcdb.2019.05.002","article-title":"Fumarate hydratase in cancer: a multifaceted tumour suppressor","volume":"98","author":"Schmidt","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.molcel.2022.01.029_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature19353","article-title":"Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition","volume":"537","author":"Sciacovelli","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2022.01.029_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","article-title":"Essential role for nuclear PTEN in maintaining chromosomal integrity","volume":"128","author":"Shen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molcel.2022.01.029_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2022.01.029_bib37","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1128\/MCB.00483-09","article-title":"Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species","volume":"29","author":"Sudarshan","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molcel.2022.01.029_bib38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2363-0","article-title":"Oncometabolites suppress DNA repair by disrupting local chromatin signalling","volume":"582","author":"Sulkowski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2022.01.029_bib39","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41588-018-0170-4","article-title":"Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair","volume":"50","author":"Sulkowski","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2022.01.029_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molcel.2013.05.003","article-title":"The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling","volume":"51","author":"Sullivan","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib41","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cmet.2021.03.003","article-title":"Malic enzyme 2 connects the Krebs cycle intermediate fumarate to mitochondrial biogenesis","volume":"33","author":"Wang","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.molcel.2022.01.029_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molcel.2007.01.005","article-title":"C-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis","volume":"25","author":"Xia","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2022.01.029_bib43","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.molcel.2022.01.029_bib44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41422-020-00443-z","article-title":"Neddylation of PTEN regulates its nuclear import and promotes tumor development","volume":"31","author":"Xie","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.molcel.2022.01.029_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13058-019-1154-8","article-title":"Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and\/or PTEN loss\/PTEN mutation","volume":"21","author":"Xing","year":"2019","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.molcel.2022.01.029_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2012.00085","article-title":"The emerging role of fumarate as an oncometabolite","volume":"2","author":"Yang","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molcel.2022.01.029_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cancergencyto.2009.08.018","article-title":"UOK 262 cell line, fumarate hydratase deficient (FH-\/FH-) hereditary leiomyomatosis renal cell carcinoma: in\u00a0vitro and in\u00a0vivo model of an aberrant energy metabolic pathway in human cancer","volume":"196","author":"Yang","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.molcel.2022.01.029_bib48","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/2159-8290.CD-18-0083","article-title":"PTEN methylation by NSD2 controls cellular sensitivity to DNA damage","volume":"9","author":"Zhang","year":"2019","journal-title":"Cancer Discov"}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276522001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276522001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:42:46Z","timestamp":1761093766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276522001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1097276522001058"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2022.01.029","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2022.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}